HOUSTON, Oct. 26, 2005 (PRIMEZONE) -- Complete Care Medical, Inc. (Pink Sheets: CCMI) announced today that Diabetes Gold, LLC, a wholly owned subsidiary of CCMI, is negotiating with a large Canadian mail order pharmacy to dispense and ship generic drugs prescriptions for the Canadian pharmacy's U.S. patients
According to J.P. Monteverde, CEO of CCMI, the discussions are expected to result in a pilot program to demonstrate the mutual benefits of the venture. "There are clear economic and operating advantages for both parties," he said. "The Canadian partner will benefit from greatly reduced paperwork demands, the much lower wholesale cost of generic drugs in the U.S., and the reduced cost of domestic rather than international shipping and, because its highly automated dispensing facility is operating at less than capacity, CarePharm can fulfill this added business and generate substantial income with no increase in operating cost."
Through its subsidiaries, Complete Care Medical, Inc. provides patients in all 50 states with lower cost alternatives for disease management, medical supplies and prescription pharmaceuticals. In addition, Complete Care Medical's discount services and medication program offers healthcare payers, healthcare providers, healthcare professionals and patients with easy access to utilization and compliance data in order to improve patient outcomes and improve quality of life.
For more information: www.ccmedicalinc.com
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties or other factors which may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as: the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels.
All information in this release is as of the date of this release. The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.